Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials
|
|
- Violet Morgan
- 6 years ago
- Views:
Transcription
1 Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials
2 Pregnancy and Congenital Heart Disease Case Review Heidi M. Connolly, M.D. Professor of Medicine Chair for Education Division of Cardiovascular Diseases Mayo Clinic, Rochester, MN
3 Disclosure I have no conflicts of interest to disclose
4 Background 2% of pregnancies involve maternal CV disease Congenital heart disease (CHD) is the most common form of HD to affect women of childbearing age in North America CV disease does not preclude pregnancy but poses risk to mother and fetus Informed CV evaluation ideal pre-pregnancy
5 Question 1
6 Pregnancy Not Advised (1) Which of the following patients would you advise avoid pregnancy? 1. Bicuspid aortic valve with moderate AS 2. Asymptomatic pt with LVEF 45% 3. Marfan syndrome pt with aorta 46 mm 4. Repaired cyanotic CHD
7 Pregnancy Not Advised Severe pulmonary arterial hypertension Severe obstructive lesions AS, MS, PS, HCM, Coarctation Ventricular dysfunction CHF - NYHA Class III or IV, EF <40% Prior peripartum cardiomyopathy Dilated or unstable aorta Marfan with aorta mm Severe cyanosis
8 Pregnancy Risk Regurgitant valve lesions generally well tolerated Complex lesions assess on case by case basis Risk of inheritance 3-5% with most CHD Genetic disorders
9 Pregnancy Not Advised (1) Which of the following patients would you advise avoid pregnancy? 1. Bicuspid aortic valve with moderate AS 2. Asymptomatic pt with LVEF 45% 3. Marfan syndrome pt with aorta 46 mm 4. Repaired cyanotic CHD
10 Case 2
11 Risk Assessment
12 Pregnancy Risk Assessment (2) 32-Year-Old seeks pre-pregnancy counseling Remote history ASD closure and mitral valve repair Paroxysmal atrial fibrillation Warfarin and beta-blocker What is the risk of maternal pregnancy related complication 1. <10% % 3. >20%
13 Pre-pregnancy Evaluation History, exam, ECG, CXR, med review Exercise testing, Echo and additional imaging Cardiac catheterization to evaluate possible pulmonary hypertension Genetic considerations
14 Prepregnancy Risk Assessment CARPREG WHO Classification ZAHARA
15 Pregnancy Outcome ZAHARA study Observational data on CHD in pregnancy 1802 women, 1302 completed pregnancies Cardiac complications in 7.6% Most common CV complications Arrhythmias 4.7% Heart failure 1.6% Drenthen et al: Eur Heart J 2010
16 Predictors of Maternal CV Complications Cyanotic heart disease (p < ) Cardiac meds pre-pregnancy (p < ) Left heart obstruction (p < ) Mechanical valve prosthesis (p = ) Systemic or pulmonary AV valve regurgitation related to complex CHD (p = 0.03) Drenthen et al: Eur Heart J 2010
17 Modified Risk Score of CV Complications During Pregnancy Cardiac complications in % of total number pregnancies History of arrhythmias 1.50 points 2. Cardiac medication before pregnancy 1.50 points 3. NYHA class prior to pregnancy points 4. LHD (PG >50 mm Hg or AVA <1.0 cm 2 ) 2.50 points 5. Syst AV valve regurgitation (moderate/severe) 0.75 points 6. Pulm AV valve regurgitation (moderate/severe 0.75 points 7. Mechanical valve prosthesis 4.25 points 8. Cyanotic heart disease (corrected/uncorrected) 1.00 points Total number of points 0-13 points >3.51 Risk score Pregnancies at risk (no.) Percentage of total population * Drenthen et al: Eur Heart J 2010
18 Pregnancy Risk Assessment (2) 32-Year-Old seeks pre-pregnancy counseling Remote ASD closure and mitral valve repair Paroxysmal AF, warfarin and B-blocker What is the risk of maternal pregnancy related complication 1. <10% % 3. >20%
19 Case 3
20 Pregnancy management
21 Management of shunt lesions in pregnancy
22 Pregnancy Case Management (3) 26-Year-Old Female One prior uncomplicated pregnancy Currently 19 weeks pregnant Occasional palpitations Low dose aspirin Murmur on physical exam Echo Secundum ASD, Right heart enlarged No pulmonary hypertension
23 Pregnancy Case Management (3) Management during pregnancy? 1. Surgical intervention 2. Device intervention 3. Observation 4. Warfarin anticoagulation
24 ASD and Pregnancy Unrepaired ASD neonatal risk vs repaired pre-eclampsia risk, SGA births fetal mortality L to R shunt may with CO change during pregnancy, balanced by PVR Paradoxical embolism risk Familial types- consider screening Warnes et al: JACC 2008
25 Evaluation during pregnancy History, exam, ECG, med review Echo and additional imaging +/- Cardiac catheterization Genetics referral/testing Frequency of cardiac follow-up depends on type of CHD
26 Pregnancy Case Management (3) Management during pregnancy? 1. Surgical intervention 2. Device intervention 3. Observation 4. Warfarin anticoagulation
27 Case 4
28 Congenital Valve and Stenotic Lesions
29 Pregnancy Case Management (4) 30-Year-Old Female Murmur since childhood, no symptoms Presents for pre-pregnancy evaluation Systolic murmur along left sternal border Echo Pulmonic valve stenosis Moderate PS mean gradient 15 mmhg Mild PR Normal right heart size and function
30 Pregnancy Case Management (4) What do you suggest? 1. OK to proceed with pregnancy 2. Balloon pulmonary valve intervention prior to pregnancy 3. Surgical intervention prior to pregnancy 4. Consultation with congenital heart specialist prior to pregnancy
31 Pulmonic Stenosis Pregnancy usually well tolerated unless very severe Percutaneous valvotomy can be performed during pregnancy No maternal CV events >100 preg Outcome Preterm delivery in 14.5% Fetal mortality 0.8% Perinatal mortality 4% Recurrent CHD 3% Noonan s syndrome Drenthen et al: JACC 2007
32 Pregnancy Case Management (4) What do you suggest? 1. OK to proceed with pregnancy 2. Balloon pulmonary valve intervention prior to pregnancy 3. Surgical intervention prior to pregnancy 4. Consultation with congenital heart specialist prior to pregnancy
33 Case 5
34 Genetic/Aortic Disorders
35 Genetic/Aortic Disorders (5) 20-Year-Old Female Pre-pregnancy counseling FH of Marfan, dissection, ectopia lentis Asymptomatic Ao root 41 mm
36 Genetic/Aortic Disorders (5) What would you recommend? 1. OK to proceed with pregnancy 2. Avoid pregnancy 3. Start beta-blocker before pregnancy 4. Start angiotensin receptor blocker before pregnancy
37 Marfan Syndrome Unpredictable maternal risk Dissection, rupture, IE, CHF Risk based on Preexisting medial changes Changes with pregnancy- Physiologic, hormonal Fetal risks- 50% inheritance Autosomal dominant
38 Preconceptual Counseling In addition to routine obstetric screening Detailed CV history, FH, medications and exam Echo aorta and valves Aortic imaging Aorta >45 mm no pregnancy Aorta 40 mm reasonable if low risk Aorta mm individualize Genetics, prenatal diagnosis
39 Pregnancy Management Management in Marfan and other aortic disorders similar During pregnancy Beta-blocker Regular aortic imaging (individualize), Fetal echo Peripartum Facilitated vaginal delivery C-section for aorta > 40 mm or increasing in size Endocarditis prophylaxis Postpartum FU - dissection risk persists Future evaluation of lactation risk
40 Genetic/Aortic Disorders (5) 20-yo Pre-pregnancy counseling FH of Marfan, dissection, ectopia lentis Ao root 41 mm What would you recommend? 1. OK to proceed with pregnancy 2. Avoid pregnancy 3. Start beta-blocker before pregnancy 4. Start angiotensin receptor blocker before pregnancy
41 Anticoagulation for Mechanical Prosthetic Valve Valve in Pregnancy
42 25-Year-Old Female (6) Mechanical St. Jude MVR Seeks prepregnancy counseling Asymptomatic Warfarin 4 mg per day, aspirin 81 mg daily Exam BP 110/60 Normal mechanical S1, no murmur Otherwise normal examination
43 Question (6) Which of following is most appropriate AC regimen for this patient when pregnant? 1. Stop warfarin; start aspirin and clopidogrel 2. Stop warfarin; start weight-based LMWH 3. Stop warfarin; start unfractionated heparin 5000 units subcutaneously twice daily 4. Continue INR adjusted warfarin
44 Anticoagulation in Pregnancy Hematologic changes clotting factor concentration platelet adhesiveness fibrinolysis and protein S activity risk thrombosis and embolism
45 Anticoagulation During Pregnancy Maternal Risks Fetal Risks
46 Warfarin in Pregnancy Low molecular weight crosses placenta Fetal AC effect and duration vs maternal Vit K dependent factors in fetal liver risk of fetal loss, prematurity, stillbirth, fetal IC hemorrhage, retroplacental hemorrhage Embryopathy risk exposure 6-12 weeks Incidence 4-10% Dose related Oakley: Br Heart J, 1995 Vitale: J Am Coll Cardiol, 1999
47 Prosthetic Valves And Pregnancy Fetal complications Warfarin 5 mg 5/33 (15%) No embryopathy Warfarin >5 mg 22/25 (88%) 9% embryopathy Vitale N et al. JACC, 1999
48 UF Heparin in Pregnancy molecular weight does not cross placenta Short half-life variable response risk pt PTT x control, 6 hr Treatment of choice late pregnancy, delivery risk of prosthetic valve thrombosis TE events, maternal and fetal mortality Long-term use osteoporosis ~30%, sterile abscesses, platelets, alopecia
49 LMWH in Pregnancy Does not cross the placenta No teratogenic effects Antithrombotic protection Potential advantages Bioavailability, administration ease osteoporosis and thrombocytopenia Melissari: Thromb & Hemost, 1992
50 LMWH in Pregnancy Weight based LMWH inadequate in pregnancy Measure anti-xa activity Peak (4 hr post) anti-xa level ~1.0 U/mL Anti-Xa adjusted LMWH with ASA vs warfarin PV thrombosis Improved fetal outcomes Barbour L: Am J Obstet Gynecol 2004 McLintock et al: BJOG 2009
51 Pregnant Patient with Mechanical Prosthesis Therapeutic anticoagulation with frequent monitoring (I) Class I Class IIa First trimester Baseline warfarin dose 5 mg/d Continue warfarin with close INR monitoring (IIa) OR Dose-adjusted LMWH 2 /d (target anti-xa level 0.8 U/mL to 1.2 U/mL 4 to 6 h post dose) (IIb) OR Dose-adjusted continuous infusion of UFH (with an aptt at least 2 control) (IIb) Baseline warfarin dose >5 mg/d Dose-adjusted LMWH 2 /d (target anti-xa level 0.8 U/mL to 1.2 U/mL 4 to 6 h post dose (IIa) OR Dose-adjusted continuous infusion of UFH (with an aptt at least 2 control) (IIa) Class IIb First trimester ACC/AHA VHD Guidelines 2014
52 Pregnant Patient with Mechanical Prosthesis Second and third trimesters Class I Warfarin to goal INR plus ASA 75 mg to 100 mg QD (I) Before planned vaginal delivery Discontinue warfarin and doseadjusted continuous infusion of UFH (with an aptt at least 2 control) (I) ACC/AHA VHD Guidelines 2014
53 25-Year-Old with Mechanical MVR Warfarin 4 mg with Therapeutic INR Which of following is most appropriate AC regimen for this patient when pregnant? 1. Stop warfarin; start aspirin and clopidogrel 2. Stop warfarin; start weight-based LMWH 3. Stop warfarin; start unfractionated heparin 5000 units subcutaneously twice daily 4. Continue INR adjusted warfarin
54 AC in Pregnancy for Mechanical Valve AC must be therapeutic Warfarin preferred in 1 st trimester if therapeutic dose is 5 mg UFH is treatment of choice near delivery LMWH can be used but for mechanical valves must be adjusted to anti-xa level
55 Conclusions Women with an MHV have only a 58% chance of experiencing an uncomplicated pregnancy with a live birth. The markedly increased mortality and morbidity warrant extensive prepregnancy counseling and centralization of care.
56 Summary 2% of pregnancies involve maternal CV disease CHD is the most common form of HD to affect women of childbearing age in North America CV disease does not preclude pregnancy but poses risk to mother and fetus Informed CV evaluation ideal pre-pregnancy
57 Questions?
Pregnancy and Heart Disease. Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA
Pregnancy and Heart Disease Shilpa Kshatriya, MD, FACC Heartland Cardiology, PA Pregnancy and the Heart 2 % of pregnancies involve maternal CV disease CV disease does not preclude pregnancy but poses risk
More informationCritical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials
Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials Pregnancy and Congenital Heart Disease Heidi M. Connolly, M.D. Professor of Medicine Chair for Education Division
More informationPregnancy and Heart Disease
Pregnancy and Heart Disease Heidi M. Connolly, MD No disclosures 2011 MFMER 3138928-1 Regitz-Zagrosek V, Lundqvist C, Borghi C, et al. Pregnancy and the Heart 2% of pregnancies involve maternal CV disease
More informationValve Disease in the Pregnant Patient
Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If
More informationCongenital Heart Disease Patient and Pregnancy
Congenital Heart Disease Patient and Pregnancy Gurur Biliciler-Denktas, M.D. Assistant Professor Division of Pediatric Cardiology, Department of Pediatrics The University of Texas Health Science Center
More informationClinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'
More informationPregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy
Pregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy Heidi M. Connolly, MD Cardiac Problems in Pregnancy Venice Italy, February 2014 No Disclosures 2012 MFMER slide-1 Regitz-Zagrosek
More informationPregnancy and Cardiovascular Disease
Pregnancy and Cardiovascular Disease Cindy M. Martin, M.D. Co-Director, Adult Congenital and Cardiovascular Genetics Center No Disclosures Objectives Discuss the hemodynamic changes during pregnancy Define
More informationCardiac Disease in Pregnancy
Cardiac Disease in Pregnancy DATE: SEPTEMBER 11, 2016 PRESENTED BY: ABIGAIL KHAN, MD Outline Scope of the problem Physiology of pregnancy Cardiac risk in pregnancy Pregnancy management Contraception 1
More informationESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy
ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION
More informationPREGNANCY AND CONGENITAL HEART DISEASE
PREGNANCY AND CONGENITAL HEART DISEASE SIDDHARTH JADHAV M.D. Assistant Professor of Radiology E.B. Singleton Department of Pediatric Radiology Texas Children's Hospital COMMERCIAL DISCLOSURE - None Objectives
More informationMaternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE
Maternal Cardiac Disease In Pregnancy August 25, 2017 PREGNANCY ECHO CONFERENCE Maternal Physiology Cardiac Output = HR x SV Non-pregnant: 4.5 L/min Pregnant: 6.0 L/min Increase most acute in first 10
More informationOutline. Maternal Congenital Heart Disease in Pregnancy. Maternal congenital heart disease. Cardiovascular disease in pregnancy 10/18/2017
I have no disclosures or conflicts of interest to report. Maternal Congenital Heart Disease in Pregnancy Jennifer A. Jolley, MD Associate Clinical Professor University of California, Irvine Department
More informationΈγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων
Έγκυος και συγγενής καρδιοπάθεια: Τι πρέπει να γνωρίζει ο Καρδιολόγος Ενηλίκων Αντώνιος Π. Βλάχος Αναπληρωτής Καθηγητής Παιδοκαρδιολογίας Πανεπιστήμιο Ιωαννίνων No conflict of interest Pregnancy and CHD
More informationA pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC
A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy *C.V. was born the 24th May 1980 Rheumatic fever during
More informationMaternal Cardiac Disease Diagnosis and Management
Maternal Cardiac Disease Diagnosis and Management Dr. Şevki ÇELEN ZTB Maternity and Teaching Hospital Department of Perinatology Heart diseases in pregnancy Today, 0.2-4% of all pregnancies are accompanied
More informationPregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia
Pregnancy, Heart Disease and Imaging Sangeeta Shah, MD, FASE, FACC Associate Professor, Ochsner Clinical School of Medicine Advanced CV Imaging and Adult Congenital Heart Disease New Orleans, LA Hemodynamics
More informationEVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE. Karen Stout, MD University of Washington Seattle Children s Seattle, WA
EVALUATION OF PREGNANT PATIENTS WITH HEART DISEASE Karen Stout, MD University of Washington Seattle Children s Seattle, WA CASE PRESENTATION 24 year old woman with aortic regurgitation referred for evaluation
More informationFocused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.
ACC/AH HA 2006 Guidel nic severe AI (Fig. 4). ned by age, ay also be helpful nd echo. For AI, ollow up may be or MRI rather than mension; SD, end lines for Manag gement of Patie Upd ents With Valvul date
More informationRF & RHD Workshop 22 nd March MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY. Dr Dorothy Radford
RF & RHD Workshop 22 nd March 2016 MANAGEMENT of RHEUMATIC HEART DISEASE in PREGNANCY Dr Dorothy Radford PREGNANCY PHYSIOLOGY Increased cardiac output 30%-50% Increased blood volume 30%-50% Increased heart
More informationPregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital
Pregnancy and Heart Disease Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital Pregnancy is not a state Hemodynamic changes During pregnancy Estrogens 1. Renin 2.
More informationPregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016
1 Pregnancy and Heart Disease Sharon L. Roble, MD Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Cardiovascular Effects of Pregnancy Anatomic Ventricular muscle mass increases
More informationΚαρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη
Καρδιοπάθειες και κύηση. Υπάρχουν ενδείξεις διακοπής; Λαζαρίδου Φωτεινή, ΕΒ Καρδιολόγος Νοσοκομείο «Αγ Παύλος», Θεσσαλονίκη ~ 3% of women 18 44 years of age have cardiac disease ~ 1% of pregnancies are
More informationValvular Heart Disease
Valvular Heart Disease B K Singh, MD, FACC Disclosures: None 1 CARDIAC CYCLE S2 S2=A2P2 S1=M1T1 S4 S1 S3 2 JVP Carotid S1 Slitting of S2 S3 S4 Ejection click Opening snap Dynamic Auscultation What is the
More informationMore History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012
The Parturient with Cardiac Disease Pamela Flood M.D. Professor of Anesthesia and Perioperative Care Obstetrics, Gynecology and Reproductive Sciences University of California, San Francisco Maternal Cardiac
More informationUptofate Study Summary
CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy
More informationCongenital heart disease. By Dr Saima Ali Professor of pediatrics
Congenital heart disease By Dr Saima Ali Professor of pediatrics What is the most striking clinical finding in this child? Learning objectives By the end of this lecture, final year student should be able
More informationACHD & Heart Disease and Pregnancy: Guidelines and Cases Michael A. Gatzoulis
ACHD & Heart Disease and Pregnancy: Guidelines and Cases Michael A. Gatzoulis Adult Congenital Heart Centre & National Centre for Pulmonary Hypertension Royal Brompton Hospital/National Heart & Lung Institute,
More informationCardiac disease in pre pr gnancy
IN THE NAME OF GOD Cardiac disease in pregn nancy MITRAL STENOSIS 33 y/o G3L2(2c/s) GA 34 + 5 CC: LP & dyspnea PMHx: MS sinse 4 yrs ago due to Rheumatism PSHx: 2c/s DHx: metoral 50 mg q6h/ ASA/ Enoxaparin
More informationThe dos and don ts των νέων Κατευθυντηρίων Οδηγιών της Ευρωπαϊκής Καρδιολογικής Εταιρείας Για την καρδιαγγειακή νόσο στην εγκυμοσύνη
The dos and don ts των νέων Κατευθυντηρίων Οδηγιών της Ευρωπαϊκής Καρδιολογικής Εταιρείας Για την καρδιαγγειακή νόσο στην εγκυμοσύνη Θωμάς Κ. Μακρής, MD FA, FES Συντονιστής Διευθυντής Καρδιολογικού Τμήματος
More informationPregnancy and cyanotic congenital heart disease. A. Pijuan Domènech (U. de C. Congènites de l Adult) Hospital Vall d Hebron Barcelona, Spain
Pregnancy and cyanotic congenital heart disease A. Pijuan Domènech (U. de C. Congènites de l Adult) Hospital Vall d Hebron Barcelona, Spain I have nothing to disclose. Pregnancy and cyanotic congenital
More informationCardiovascular disease complicates 1% to 3% of all
Pregnancy Complicated by Valvular Heart Disease: An Update Michael Nanna, MD; Kathleen Stergiopoulos, MD, PhD, FASE, FACC, FAHA Cardiovascular disease complicates 1% to 3% of all pregnancies and is responsible
More informationCandice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada
PVR Following Repair of TOF Now? When? Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada Late Complications after TOF repair Repair will be necessary
More informationAnatomy & Physiology
1 Anatomy & Physiology Heart is divided into four chambers, two atrias & two ventricles. Atrioventricular valves (tricuspid & mitral) separate the atria from ventricles. they open & close to control flow
More informationCatherine Nelson-Piercy. Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK
Cardiac Disease and Pregnancy Catherine Nelson-Piercy Guy s & St Thomas Hospitals & Queen Charlotte s Hospital London, UK Physiological changes in pregnancy Cardiac Output (CO) increases by 40% Further
More informationPATENT DUCTUS ARTERIOSUS (PDA)
PATENT DUCTUS ARTERIOSUS (PDA) It is a channel that connect the pulmonary artery with the descending aorta (isthumus part). It results from the persistence of patency of the fetal ductus arteriosus after
More informationEffect of maternal heart disease on pregnancy outcomes
Expert Review of Obstetrics & Gynecology ISSN: 1747-4108 (Print) 1747-4116 (Online) Journal homepage: http://www.tandfonline.com/loi/ierb20 Effect of maternal heart disease on pregnancy outcomes Emily
More informationImaging Cardiovascular Disease in Pregnancy
Imaging Cardiovascular Disease in Pregnancy Karen Ordovas MD, MAS Associate Professor of Radiology and Medicine Director of Cardiac Imaging University of California San Francisco Cardiac MRI during pregnancy
More informationAdult Congenital Heart Disease: What Every Practitioner Should Know
Adult Congenital Heart Disease: What Every Practitioner Should Know Sabrina Phillips, MD FACC FASE Associate Professor of Medicine Director of Adult Congenital Heart Disease Services The University of
More informationSESSION D5. The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM
37th Annual Advanced Practice in Primary and Acute Care Conference: October 9-11, 2014 2:45 SESSION D5 Session Description: The Heart of the Matter: Cardiac Disease in Pregnancy Brad M. Dolinsky, MD, MFM
More informationAntithrombotic therapy for patients with congenital heart disease. George Giannakoulas, MD, PhD AHEPA University Hospital Thessaloniki
Antithrombotic therapy for patients with congenital heart disease George Giannakoulas, MD, PhD AHEPA University Hospital Thessaloniki Disclosures Educational fees from Astra Zeneca, GSK Research fees from
More informationManagement of Heart Failure and Cardiomyopathies in Pregnancy
Management of Heart Failure and Cardiomyopathies in Pregnancy Professor Sanjay Sharma Disclosures: None Epidemiology of Cardiac Disease In Pregnancy Cardiovascular disease in pregnancy is increasing in
More informationΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ
ΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ European Accreditation in TTE, TEE and CHD Echocardiography NOTHING TO DECLARE ATRIAL SEPTAL DEFECT TYPES SECUNDUM
More informationPREGNANCY IN PATIENTS WITH A SYSTEMIC RV
PREGNANCY IN PATIENTS WITH A SYSTEMIC RV Carole A. Warnes MD, FRCP Professor of Medicine, Mayo Clinic No disclosures 2013 MFMER slide-1 PREGNANCY : SYSTEMIC RV D - transposition after atrial switch procedure
More informationDr.ssa Loredana Iannetta. Centro Cardiologico Monzino
Dr.ssa Loredana Iannetta Centro Cardiologico Monzino Bicuspid aortic valve BAV is the most common congenital cardiac anomaly. Estimated incidence is 2% in general population. 4:1 male predominance. Frequency
More informationInterventions in Adult Congenital Heart Disease: Role of CV Imaging. Associate Professor. ACHD mortality. Pillutla. Am Heart J 2009;158:874-9
Interventions in Adult Congenital Heart Disease: Role of CV Imaging Sangeeta Shah MD, FACC, FASE Associate Professor ACHD mortality Pillutla. Am Heart J 2009;158:874-9 Adult Congenital Heart Disease Heterogenity
More informationUsing an anti-xa level nomogram to adjust intravenous unfractionated heparin infusion for arrhythmia in pregnancy
Using an anti-xa level nomogram to adjust intravenous unfractionated heparin infusion for arrhythmia in pregnancy W. Sia, E. Toor, N. Wahab, J. Windram, R. Khurana Cardiac Problems in Pregnancy Congress
More informationMiscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease. Pregnancy and Cardiovascular Disease MCQ
Miscellaneous Cardiology Topics pregnancy - congenital - myocarditis - pericardial disease Maan Jokhadar, MD, FACC Emory Center for Advanced Heart Failure Therapy Emory Adult Congenital Heart Center Pregnancy
More informationMITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center
MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT Irene Frantzis P year, SGUL Sheba Medical Center MITRAL VALVE DISEASE Mitral Valve Regurgitation Mitral Valve Stenosis Mitral Valve Prolapse MITRAL REGURGITATION
More informationHow to manage the pregnant woman with heart disease
How to manage the pregnant woman with heart disease Dr Fiona Walker, The Heart Hospital,UCLH, London Dr Sara Thorne, University Hospital Birmingham Dr Cathy Head, The Heart Hospital, UCLH, London Dr Kate
More informationValvular Heart Disease Mitral Stenosis
Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema
More informationPregnant woman with congenital heart disease. A. Pijuan Domènech (U. de C. Congènites de l Adult) ACOR, Hospital Vall d Hebron Barcelona, Spain
Pregnant woman with congenital heart disease A. Pijuan Domènech (U. de C. Congènites de l Adult) ACOR, Hospital Vall d Hebron Barcelona, Spain Pregnant women with congenital heart disease Maternal mortality/10e6
More informationImages in Cardiovascular Medicine
Images in Cardiovascular Medicine Management of Severe Mitral Stenosis During Pregnancy Rebecca S. Norrad, MBBS; Omid Salehian, MSc, MD, FRCPC, FACC, FAHA A 37-year-old woman originally from Iraq was referred
More informationHeart Failure treatment during pregnancy
Heart Failure treatment during pregnancy Angeles Alonso García Hospital Universitario Puerta de Hierro. Majadahonda. Madrid. Spain European Society of Cardiology. Stockholm. 29 August 2010 Starting Point
More information42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim
42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of
More informationECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT
ECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT Karen Stout, MD, FACC Divisions of Cardiology University of Washington Medical Center Seattle Children s Hospital NO DISCLOSURES
More informationPeripartum management of Rheumatic Heart Disease
Peripartum management of Rheumatic Heart Disease Dr James Sartain Director of Anaesthesia & Perioperative Medicine Cairns & Hinterland Hospital & Health Service Talk outline Why (still) talk about RHD
More informationAnticoagulation Therapy and Valve Surgery. Dr Pau Kiew Kong Consultant Cardiothoracic Surgeon
Anticoagulation Therapy and Valve Surgery Dr Pau Kiew Kong Consultant Cardiothoracic Surgeon Outline of lecture 1. Type of Valve Surgery 2. Anticoagulation requirements 3. Mechanical (Metallic) prosthetic
More informationHEART DISEASE IN PREGNANCY
HEART DISEASE IN PREGNANCY DR. JOSHI SUYAJNA D. www.suyajna.com VIMS-BELLARY Pre-conceptional counseling a. Objective Risk assessment with» 1. Clarke s table 2. NYHA b. Feasibility of pregnancy care c.
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More informationHeart Valves: Before and after surgery
Heart Valves: Before and after surgery Tim Sutton, Consultant Cardiologist Middlemore Hospital, Auckland Auckland Heart Group Indications for intervention in Valvular disease To prevent sudden death and
More informationUpdate on Oral Anticoagulation for Mechanical Heart Valves
Update on Oral Anticoagulation for Mechanical Heart Valves Douglas C. Anderson, Pharm.D., D.Ph. Professor and Chair Dept. of Pharmacy Practice Cedarville University School of Pharmacy OHIO SOCIETY OF HEALTH-SYSTEM
More informationThROmbolytIc TherApy of Prosthetic Heart Valve Thrombosis in PREGnancy with Low Dose Slow Infusion of t-pa (TROIA-PREG)
ThROmbolytIc TherApy of Prosthetic Heart Valve Thrombosis in PREGnancy with Low Dose Slow Infusion of t-pa (TROIA-PREG) Beytullah ÇAKAL, MD Koşuyolu Kartal Heart Training and Research Hospital, Istanbul,
More informationAsif Serajian DO FACC FSCAI
Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac
More informationAdult Cardiac Surgery
Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease
More informationValvular Heart Disease. Dr. HANAN ALBACKR
Valvular Heart Disease Dr. HANAN ALBACKR Valvular Heart Disease Format for this lecture IMPORTANT CLINICAL INFO know for boards, tests and clinical practice Spectrum of VHD Aortic Valve Mitral Valve Tricuspid
More informationMaternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 19 Number 1 Maternal And Fetal Outcome In Pregnancies Complicated With Maternal Cardiac Diseases: Experience At A Tertiary Care Hospital
More informationPrimary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017
Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board
More informationDECLARATION OF CONFLICT OF INTEREST. No disclosures
DECLARATION OF CONFLICT OF INTEREST No disclosures Congenital Aortic Valve Disease and Aortopathy: Recent Advances Sub- and Supravalvular Aortic Stenosis Westfälische Wilhelms-Universität Münster Helmut
More informationUC SF DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE OBJECTIVES. No financial disclosures CARDIOVASCULAR CHANGES ANTEPARTUM 6/10/2011
DISCLOSURES MANAGEMENT OF MATERNAL CONGENITAL HEART DISEASE No financial disclosures UC SF Lena H. Kim, MD AIM CONFERENCE June 10, 2011 spicecomments.com OBJECTIVES Physiologic cardiovascular changes of
More informationAdults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP
Adults with Congenital Heart Disease Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP Outline History of CHD Statistics Specific lesions (TOF, TGA, Single ventricle) Erythrocytosis Pregnancy History
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationCases in Adult Congenital Heart Disease
Cases in Adult Congenital Heart Disease Sabrina Phillips, MD FACC FASE Associate Professor of Medicine The University of Oklahoma Health Sciences Center No Disclosures I Have Palpitations 18 Year old Man
More informationWhat to do when a heart failure patient becomes pregnant
BSH Heart Failure Day for Revalidation and Training 2017 What to do when a heart failure patient becomes pregnant Dr Diane Barker Consultant Cardiologist Royal Stoke Hospital Conflicts of interest - sponsorship,
More informationCongenital Heart Disease Cases
Congenital Heart Disease Cases Sabrina Phillips, MD FACC FASE Mayo Clinic Congenital Heart Disease Center 2013 MFMER slide-1 No Disclosures 2013 MFMER slide-2 1 CASE 1 2013 MFMER slide-3 63 year old Woman
More information2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease
2017 Update to the AHA/ACC Guideline for Management of Mitral Valve Disease Patrick T. O Gara, MD BWH Heart and Vascular Center Professor of Medicine, Harvard Medical School Disclosures NHLBI CTSN Co-chair
More informationHeart failure in pregnancy
Heart failure in pregnancy PD Dr. med Daniel Tobler Leiter angeborene Herzfehler (GUCH) Universitätsspital Basel! www.heartdiseaseandpregnancy.com Heart failure in pregnancy Agenda! - general considerations
More informationHow pregnancy impacts adult cyanotic congenital heart disease
How pregnancy impacts adult cyanotic congenital heart disease Magalie Ladouceur Adult Congenital Heart Disease Unit, Hôpital Européen Georges Pompidou, Centre de reference des Malformations Cardiaques
More informationATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION
ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships
More informationRate of CHD at birth: 4~12/1,000
Risk assessment and management for the pregnant ACHD woman Suk-Joo Choi Department of Obstetrics and Gynecology Samsung Medical Center Sungkyunkwan k University i School of Medicine i Cardiac diseases
More informationEcho Doppler Assessment of Right and Left Ventricular Hemodynamics.
Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP Northwell, Lenox Hill Hospital, New York Professor of Cardiology Hofstra University
More informationComprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.
Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP North Shore HS, LIJ/Lenox Hill Hospital, New York
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acid base balance pregnancy-related changes to, 640 Acquired heart disease, 731 Acute fatty liver of pregnancy (AFLP), 618 Acute kidney
More informationHow does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ
How does taking warfarin affect Exercise Regimen? By Dr.*~LoOKTaO ~* ÿ no consistent recommendations available regarding safety of certain sports & exercise any sports w/ high risk of trauma, especially
More informationSurvival Rates of Children with Congenital Heart Disease continue to improve.
DOROTHY RADFORD Survival Rates of Children with Congenital Heart Disease continue to improve. 1940-20% 1960-40% 1980-70% 2010->90% Percentage of children with CHD reaching age of 18 years 1938 First Patent
More informationUnderstanding the guidelines for Interventions in MR. Ali AlMasood
Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe
More information2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17
2017 Bryan Health Primary Care Conference Dale Hansen MD Bryan Heart 5/20/17 I have no financial disclosures or conflicts of interest Bridging Anticoagulation Primum Non Nocere 67 y.o. male with mechanical
More informationP = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation
Comprehensive Hemodynamic Evaluation by Doppler Echocardiography Itzhak Kronzon, MD North Shore LIJ/ Lenox Hill Hospital New York, NY Disclosure: Philips Healthcare St. Jude Medical The Simplified Bernoulli
More informationClosing ASDs with pulmonary hypertension. Shakeel A Qureshi Evelina Children s Hospital London
Closing ASDs with pulmonary hypertension Shakeel A Qureshi Evelina Children s Hospital London Ho Chi Minh, Vietnam, January 2012 ACC/AHA 2008 Guidelines ASD closure Closure is indicated for right atrial
More informationAnaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO)
Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO) Dr. Siân Jaggar Consultant Anaesthetist Royal Brompton Hospital London UK Congenital Cardiac Services
More informationClinical Practice Committee Anticoagulation Bridging Document
Original: 10/23/06 Last Updated: 10/30/07 Clinical Practice Committee Do patients on long term oral anticoagulant therapy who require short term interruption of warfarin for an elective invasive procedure
More informationReview Article Heart Disease and Pregnancy
Hellenic J Cardiol 47: 275-291, 2006 Review Article Heart Disease and Pregnancy AIKATERINI CHAMAIDI, MICHAEL A. GATZOULIS Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton
More informationPeripartum Cardiomyopathy. Lavanya Rai Manipal
Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationThe production of murmurs is due to 3 main factors:
Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or
More informationAdult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute
Adult Congenital Heart Disease: A Growing Problem Dr. Gary Webb Cincinnati Children s Hospital Heart Institute ACHD Resources in Ohio ACHAHEART.ORG Situations When We Might Help When you don t know a
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationAtrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology
Atrial Fibrillation Ivan Anderson, MD RIHVH Cardiology Outline Definition and Pathophysiology Rate versus rhythm control Rate control thresholds (how much is enough) Anti-coagulation CHADS2VASc score HASBLED
More information2) VSD & PDA - Dr. Aso
2) VSD & PDA - Dr. Aso Ventricular Septal Defect (VSD) Most common cardiac malformation 25-30 % Types of VSD: According to position perimembranous, inlet, muscular. According to size small, medium, large.
More information5.8 Congenital Heart Disease
5.8 Congenital Heart Disease Congenital heart diseases (CHD) refer to structural or functional heart diseases, which are present at birth. Some of these lesions may be discovered later. prevalence of Chd
More information